W
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
Price:
0.33
INR
-2.94%
Market Closed
Market Cap:
₹407.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
W
|
Welcure Drugs and Pharmaceuticals Ltd
BSE:524661
|
IN |
Balance Sheet
Balance Sheet Decomposition
Welcure Drugs and Pharmaceuticals Ltd
Welcure Drugs and Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Welcure Drugs and Pharmaceuticals Ltd
Welcure Drugs and Pharmaceuticals Ltd
Balance Sheet
Welcure Drugs and Pharmaceuticals Ltd
Welcure Drugs and Pharmaceuticals Ltd
Currency: INR
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
1
|
3
|
2
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Cash |
2
|
1
|
3
|
2
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
195
|
|
| Total Receivables |
101
|
102
|
31
|
23
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
190
|
|
| Accounts Receivables |
81
|
87
|
17
|
11
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
190
|
|
| Other Receivables |
20
|
15
|
14
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
16
|
7
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 435
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
118
|
111
|
36
|
25
|
4
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1 821
|
|
| PP&E Net |
64
|
60
|
55
|
44
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
60
|
55
|
44
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
32
|
36
|
36
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
13
|
847
|
|
| Long-Term Investments |
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Other Long-Term Assets |
44
|
55
|
114
|
132
|
123
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
230
N/A
|
228
-1%
|
205
-10%
|
201
-2%
|
127
-37%
|
0
-100%
|
1
+25%
|
1
N/A
|
1
+19%
|
0
-74%
|
0
+175%
|
0
-45%
|
0
+27%
|
0
-17%
|
1
+197%
|
1
+33%
|
15
+1 479%
|
14
-10%
|
2 670
+19 373%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
70
|
78
|
51
|
51
|
4
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
384
|
|
| Total Current Liabilities |
70
|
78
|
51
|
51
|
4
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
413
|
|
| Long-Term Debt |
37
|
28
|
32
|
27
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 232
|
|
| Total Liabilities |
107
N/A
|
105
-2%
|
83
-22%
|
78
-5%
|
4
-95%
|
1
-66%
|
1
N/A
|
1
N/A
|
1
+3%
|
0
-97%
|
0
-9%
|
0
-1%
|
0
+69%
|
0
+69%
|
0
-65%
|
0
+6%
|
0
+257%
|
0
+125%
|
1 645
+537 376%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
134
|
134
|
1 124
|
|
| Retained Earnings |
2
|
2
|
2
|
2
|
2
|
122
|
122
|
122
|
122
|
121
|
121
|
121
|
121
|
121
|
120
|
120
|
119
|
121
|
99
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
123
N/A
|
123
+0%
|
123
N/A
|
123
N/A
|
123
0%
|
1
N/A
|
1
+20%
|
1
N/A
|
1
+8%
|
0
N/A
|
0
+238%
|
0
-49%
|
0
+20%
|
0
-40%
|
1
+386%
|
1
+34%
|
15
+1 529%
|
13
-12%
|
1 025
+7 548%
|
|
| Total Liabilities & Equity |
230
N/A
|
228
-1%
|
205
-10%
|
201
-2%
|
127
-37%
|
0
-100%
|
1
+25%
|
1
N/A
|
1
+19%
|
0
-74%
|
0
+175%
|
0
-45%
|
0
+27%
|
0
-17%
|
1
+197%
|
1
+33%
|
15
+1 479%
|
14
-10%
|
2 670
+19 373%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
149
|
1 238
|
|
Switch to:
Switch to:
See Also
Discover More
